| SN. |
Smith & Nephew
|
FTSE 100
| 2.52 |
£9.6B
| 1,101.00 | 0.41% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 1.63 |
£5.95B
| 288.80 | -0.48% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 1.06 |
£873.99M
| 224.00 | 3.23% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£824.25M
| 315.00 | 0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.21 |
£464.84M
| 214.00 | 3.10% |
| NIOX |
Niox Group
|
AIM
| 1.93 |
£270.49M
| 65.60 | |
| TSTL |
Tristel
|
AIM
| 3.32 |
£194.43M
| 400.00 | 1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£119.01M
| 26.75 | 1.00% |
| SDI |
SDI Group
|
AIM
| |
£96.19M
| 89.50 | -1.50% |
| CREO |
Creo Medical Group
|
AIM
| |
£54.33M
| 13.75 | -0.80% |
| SPEC |
Inspecs Group
|
AIM
| |
£49.82M
| 49.38 | -0.30% |
| KMK |
Kromek Group
|
AIM
| |
£39.95M
| 6.05 | 8.70% |
| NCYT |
Novacyt SA
|
AIM
| |
£28.48M
| 42.30 | 4.20% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£21.07M
| 23.50 | 0.60% |
| POLX |
Polarean Imaging
|
AIM
| |
£16.9M
| 1.40 | -3.20% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£14.02M
| 33.50 | -0.40% |
| RUA |
RUA Life Sciences
|
AIM
| |
£8.3M
| 12.63 | -6.90% |
| FAB |
Fusion Antibodies
|
AIM
| |
£7.16M
| 6.36 | 25.90% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£6.53M
| 0.65 | -2.30% |
| GENI |
Genincode
|
AIM
| |
£6.45M
| 2.25 | 1.40% |
| MHC |
MyHealthChecked
|
AIM
| |
£5.59M
| 10.75 | 5.30% |
| BELL |
Belluscura
|
AIM
| |
£2.91M
| 0.72 | -1.10% |
| PYC |
Physiomics
|
AIM
| |
£1.49M
| 0.47 | -3.80% |
| TRLS |
Trellus Health
|
AIM
| |
£1.05M
| 0.65 | 7.30% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |